ROYAL BANK OF CANADA - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 80 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$37,000
-82.0%
3,575
-71.3%
0.00%
Q2 2023$205,00012,460
+6130.0%
0.00%
Q2 2022$0
-100.0%
200
-70.0%
0.00%
Q1 2022$4,000
-42.9%
667
-10.3%
0.00%
Q4 2021$7,000
-30.0%
744
-20.7%
0.00%
Q3 2021$10,000
+400.0%
938
+122.8%
0.00%
Q2 2021$2,000
-60.0%
421
-18.4%
0.00%
Q1 2021$5,000
-16.7%
516
-40.6%
0.00%
Q4 2020$6,000
+500.0%
869
-13.1%
0.00%
Q1 2019$1,0000.0%1,000
+300.0%
0.00%
Q4 2018$1,000
-95.5%
250
-95.0%
0.00%
Q3 2018$22,000
-35.3%
5,000
-9.6%
0.00%
Q2 2018$34,000
-41.4%
5,532
-31.2%
0.00%
Q1 2018$58,000
+18.4%
8,038
+33.3%
0.00%
Q4 2017$49,000
-23.4%
6,029
+0.5%
0.00%
Q3 2017$64,000
-3.0%
6,0000.0%0.00%
Q2 2017$66,000
+13.8%
6,000
-1.3%
0.00%
Q1 2017$58,0006,0770.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q1 2021
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,625,000$12,269,0003.04%
GENDELL JEFFREY L 1,146,764$8,658,0001.11%
Broadfin Capital, LLC 1,029,012$7,769,0001.04%
RTW INVESTMENTS, LP 3,401,434$25,681,0000.97%
BRANDES INVESTMENT PARTNERS, LP 3,651,948$27,571,0000.66%
Aristides Capital LLC 71,520$540,0000.42%
Tekla Capital Management LLC 814,588$6,150,0000.23%
INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV 36,100$273,0000.17%
Leap Investments LP 43,481$328,0000.15%
Brown Capital Management 1,829,886$13,816,0000.13%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders